Shares of Lonza Group Ag (OTCMKTS:LZAGY – Get Free Report) saw unusually-high trading volume on Thursday . Approximately 314,549 shares traded hands during trading, an increase of 577% from the previous session’s volume of 46,487 shares.The stock last traded at $70.5521 and had previously closed at $70.72.
Lonza Group Price Performance
The company has a quick ratio of 0.87, a current ratio of 1.46 and a debt-to-equity ratio of 0.48. The stock has a fifty day moving average of $67.71 and a two-hundred day moving average of $68.76.
Lonza Group Company Profile
Lonza Group is a Swiss multinational life sciences company that provides products and services to the pharmaceutical, biotech and specialty ingredients markets. Headquartered in Switzerland, the company operates globally with manufacturing and research facilities across Europe, North America and Asia, serving customers involved in drug discovery, development and commercial production. Lonza’s client base ranges from large pharmaceutical firms to emerging biotech companies and manufacturers of consumer health and specialty chemical products.
The company’s core activities center on contract development and manufacturing (CDMO) for small molecules and biologics, including process development, clinical and commercial-scale manufacturing, and fill–finish services.
See Also
- Five stocks we like better than Lonza Group
- The Crash Has Already Started (Most Just Don’t See It Yet)
- Trump’s AI Secret: 100X Faster Than Nvidia
- New gold price target
- Trump Planning to Use Public Law 63-43: Prepare Now
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.
